N/A
Completed N=38
Effects of Varenicline on Brain Activity During Nicotine Abstinence
Source: ClinicalTrials.gov NCT00602927 ↗Enrolled (actual)
38
Serious AEs
0.0%
Results posted
May 2011
Primary outcomePrimary: Percent Change BOLD Signal — 0.48; 0.61 BOLD Signal Change (3-back minus 0-back)
Summary
This project aims to define mechanisms through which varenicline might be an effective smoking cessation medication.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change BOLD Signal |
0.48; 0.61 | — |
| SECONDARY Effect of Varenicline Treatment on Task Performance (N-back Correct Response Time) |
692.14; 637.99 | — |
Eligibility Criteria
Inclusion Criteria
- Treatment-seeking smokers between the ages of 18 and 65, that smoke at least 10 cigarettes/day for at least the past 6 months
- Provide a baseline CO (carbon monoxide) reading of >10ppm
- Provide written informed consent and are fluent, English-speaking
- Weight of equal to or less than 300 lbs
Exclusion Criteria
Smoking Behavior
- Use of chewing tobacco, snuff or cigars
- Current enrollment or plans to enroll in another smoking cessation program in the next 5 months
- Plan to use other nicotine substitutes or smoking cessation treatments in the next 5 months
- Provide a baseline CO (carbon monoxide) reading ≤10 ppm
Alcohol/Drug Exclusion Criteria
- History of substance abuse and/or currently receiving treatment for substance abuse
- Current alcohol consumption that exceeds 25 standard drinks/week
- A breath alcohol concentration reading ≥ 0.01 at the H&P (health & physical) screening or either of the lab sessions
Medication Exclusion Criteria
- Prior use of Chantix
- Current use or recent discontinuation (within last 14-days) of the following medications:
- Any form of smoking cessation medication
- Any form of anti-psychotic medications that includes:
- antipsychotics,
- atypical antipsychotics,
- mood-stabilizers,
- anti-depressants (tricyclic, SSRI, MAOI),
- anti-panic agents,
- anti-obsessive agents,
- anti-anxiety agents, and
- stimulants (e.g., Provigil, Ritalin)
- herbal medications (St. John's Wort)
- Opioid medication for chronic pain
- Anti-coagulants
- Any heart medications
- Daily medication for asthma
Medical Exclusion Criteria
- Women who are pregnant, planning a pregnancy, or lactating;
- History or current diagnosis of psychosis, current major depression, bipolar disorder, ADHD, schizophrenia, or any Axis 1 disorder as identified by the MINI
- Serious or unstable disease within the past 6 months (heart disease, HIV)
- Diagnosis of cancer in the past 6 months or if successful treatment for cancer has not ended within the past 6 months
- History of epilepsy or a seizure disorder
- History or current diagnosis (last 6-months) of abnormal rhythms and/or tachycardia (>100 beats/minute); history or current diagnosis of COPD (chronic obstructive pulmonary disease), cardiovascular disease (stroke, angina, coronary heart disease), heart attack in the last 6 months, uncontrolled hypertension (SBP>150 or DBP>90)
- History of kidney and/or liver failure (including transplant)
- History of head trauma or prior seizure; family history of a seizure disorder, brain (or central nervous system) tumor
- Use of pacemakers, certain metallic implants, or presence of metal in the eye as contraindicated for MRI (magnetic resonance imaging);
- Low or borderline intellectual functioning - determined by receiving a score <80 on the Shipley verbal IQ Test
- Non-English speaking; determined at phone screen
- History of claustrophobia (contraindicated for MRI) or color blindness (task requires color recognition); self-report at telephone screen
- Being left-handed
- Any fore-limb deformity
- Wearing cochlear implant or bi-lateral hearing aids
General Exclusion
- Any medical condition or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator and/or Study Physician.
- Inability to provide informed consent or complete any of the study tasks as determined by the Principal Investigator and/or Study Physician.
- Any physical or visual impairment that may prevent the individual from using a computer keyboard or completing any study tasks.
Data sourced from ClinicalTrials.gov (NCT00602927). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.